This trial reports that a less invasive but effective treatment, stereotactic body radiation therapy (SBRT), is well-tolerated for early stage lung cancer in medically inoperable patients.
- Lung Cancer
1 Primary · 1 Secondary · Reporting Duration: 5 years
1 Treatment Group
1 of 1
150 Total Participants · 1 Treatment Group
Primary Treatment: EBUS-TBNA · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any available slots for patients to join the clinical trial?
"Affirmative. The clinicaltrial.gov database reveals that this trial, which was initially launched on February 1st 2021, is currently recruiting. Approximately 150 participants need to be sourced from a single site." - Anonymous Online Contributor
What is the aggregate participation rate in this trial?
"Affirmative. Clinicaltrials.gov contains details confirming that this clinical trial is actively recruiting participants, beginning on February 1st 2013 and last updated on October 31st 2022. This experiment aims to enrol 150 volunteers from a single site." - Anonymous Online Contributor